Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new study found viral monkeypox DNA on multiple surfaces, personal protective equipment, and in air samples in hospital isolation rooms. For some of the samples, the viral particles were capable of replicating and therefore could potentially infect other people.

A hospital room

Monkeypox virus can be shed into the surrounding environment by people who are infected, particularly in shed skin particles and in debris from monkeypox skin lesions and scabs. The virus is relatively hardy and under appropriate conditions can remain infectious on surfaces for weeks, creating a potential infection risk to others.

The UK Health Security Agency (UKHSA) recommends that patients with monkeypox who have severe disease requiring hospital admission are cared for in isolation rooms, with infection prevention and control (IPC) precautions that aim to contain potentially infectious virus within the room and protect staff who enter. However, to date it has been unclear whether these measures are proportionate to the potential virus exposure risks.

To investigate this, researchers from the Liverpool School of Tropical Medicine, the University of Oxford’s Nuffield Department of Medicine and the UKHSA conducted a study which collected samples from the rooms of patients hospitalised with monkeypox. The findings have been published in The Lancet Microbe.

The research team assessed the extent of virus shedding onto surfaces in specialist isolation rooms containing patients admitted to hospital for the management of severe monkeypox. They also investigated whether the virus was detectable in air samples from the rooms.

Viral DNA shed by the patients could be found on multiple surfaces throughout the isolation rooms (56 (93%) positive by PCR out of 60 samples). Monkeypox virus DNA was also found on personal protective equipment (PPE) worn by healthcare workers caring for these patients, and in the anterooms where they remove their PPE. Monkeypox virus DNA was also detected in five out of twenty air samples taken within these isolation rooms.

Changing bed linen was an activity particularly associated with detection of monkeypox virus DNA in air samples in the room. This suggests that viral particles, probably in shed skin particles, can become suspended in the air when bed sheets are changed. Monkeypox virus capable of replicating in cells under laboratory conditions (an indicator that the virus could infect other people) was identified in two of four PCR-positive samples selected for virus isolation. This includes air samples collected during the bed linen change.

Lead author, Dr Susan Gould, from the Liverpool School of Tropical Medicine, said ‘Our results found that changing a patient’s bedding appears to be particularly associated with an increased ability to detect monkeypox virus in air samples. In 2018, a UK healthcare worker was thought to have developed monkeypox after being exposed to the virus while changing a patient’s bedding, before monkeypox had been considered and diagnosed. Our results suggest that changing bed linen used by hospitalised patients with monkeypox does indeed increase the risk of exposure to virus, by disturbing virus on bed linen and allowing it to be suspended in the air.’

In addition to detecting virus DNA, the researchers were able to isolate replication-competent virus in some surface and air samples. The results show, for the first time, that monkeypox virus in some air samples taken around patients hospitalised with monkeypox is capable of replicating in cells and is not just ‘dead’ virus. Dr Gould said ‘These results suggest that monkeypox virus shed into a hospitalised patient’s environment poses an infection risk that needs to be managed.’

Senior author on the paper, Dr Jake Dunning, of the University of Oxford’s Nuffield Department of Medicine and the Royal Free London NHS Foundation Trust, said ‘It is important to note that detection of virus, even when demonstrated to be infectious, does not necessarily mean that exposure to the virus in real life would result in infection of the exposed person. However, it does reveal a potential transmission risk and one that is reasonable to control in hospital settings. Our results confirm that the strict IPC measures we follow in specialist infectious diseases centres are necessary and appropriate.’

This investigation specifically evaluated exposure risks when caring for patients admitted to specialist facilities in hospitals. The results and recommendations may therefore not apply to other settings, such as outpatient clinics where patients attend for a short time, interactions differ, and the virus is unlikely to accumulate to such an extent. There is no suggestion that transmission of monkeypox virus via aerosols is a common way for the infection to spread from one person to another.

Dr Gould added ‘In the context of ward-based care, our results support infection prevention and control measures designed to protect against exposure to infectious virus on surfaces and in the air, such as appropriate PPE, as well as applying measures designed to contain shed virus within hospitalised patients’ isolation rooms, including the use of negative pressure rooms and doffing areas.’

The study was led by scientists from the Liverpool School of Tropical Medicine and the University of Oxford, as part of the National Institute for Health and Care Research Health Protection Unit in Emerging and Zoonotic Infections, which includes the University of Liverpool as a partner. The HPRU in Emerging and Zoonotic Infections and UKHSA identified a need for environmental sampling in hospitals managing inpatients with monkeypox and rapidly began investigations. Prior to publication the team shared its results with those caring for patients with monkeypox admitted to hospitals in the UK, and with international partners, infectious diseases specialist networks, and public health organisations.

Dr Dunning said: ‘This work demonstrates the ability of HPRUs to conduct rapid, reactive studies to obtain data from novel outbreaks, focussing on research that informs public health guidance and policies, as well as improving patient care.’

Similar stories

New genetic mutation linked to rare conditions

Researchers from Wellcome Centre for Human Genetics at the Nuffield Department of Medicine, have discovered that a rare type of genetic variant can be responsible for two well-known skeletal disorders.

Essential research by COI improves understanding of COVID

Since the start of the pandemic, the CAMS-Oxford Institute (COI) has carried out 11 projects to better understand COVID-19, resulting in 21 published research articles.

Study opens a pathway to better diagnosis and treatment of autoimmune diseases

A study published in Nature by researchers from Washington University School of Medicine in St. Louis, Stanford University School of Medicine and Oxford University have developed a way to find the crucial protein fragment that drives autoimmunity, as well as the immune cells that respond to it.

Constant genetic surveillance needed to counter multidrug-resistant malaria strains

Continual monitoring of genetic changes in parasite populations is a powerful tool for analysing malaria outbreaks and identifying emerging multidrug-resistant malaria strains, say researchers from NDM’s Mahidol-Oxford Tropical Medicine Research Unit (MORU).

Lancet study informs WHO guidelines for the treatment of malaria in pregnancy

The study from the Worldwide Antimalarial Resistance Network (WWARN) provides compelling evidence that artemether-lumefantrine should now replace quinine as the treatment of choice in the first trimester.

Bacterial infections linked to one in eight global deaths, according to GRAM study

Data showing 7.7 million deaths from 33 bacterial infections can guide measures to strengthen health systems, particularly in low-income settings